Latest AI and machine learning research in dementia for healthcare professionals.
BACKGROUND: Dementia is increasing in prevalence worldwide, yet frequently remains undiagnosed, espe...
BACKGROUND: Amyloid-β peptide (Aβ) is involved in the formation of senile plaques in Alzheimer's dis...
Graphs are widely used as a natural framework that captures interactions between individual elements...
In recent years, machine learning approaches have been successfully applied to the field of neuroima...
We analyzed the factors associated with dementia in the elderly attended at a memory outpatient clin...
Different modalities such as structural MRI, FDG-PET, and CSF have complementary information, which ...
The number of people diagnosed with dementia is expected to rise in the coming years. Given that the...
BACKGROUND: Diagnosis of Alzheimer's disease (AD) is very important, and MRI is an effective imaging...
OBJECTIVES: To explore whether severity of cognitive impairment and agitation of older people with d...
Brain-wide and genome-wide association (BW-GWA) study is presented in this paper to identify the ass...
BACKGROUND: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) developed a neuro...
Alzheimer's disease (AD) is a progressive brain disease. The goal of this study is to provide a new ...
Early diagnosis is critical for individuals with Alzheimer's disease (AD) in clinical practice becau...
Discriminating Alzheimer's disease (AD) from its prodromal form, mild cognitive impairment (MCI), is...
Dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) require differential management despite...
To develop a new method for measuring Alzheimer's disease (AD)-specific similarity of cortical atrop...
BACKGROUND: There is a spectrum of the progression from healthy control (HC) to mild cognitive impai...
Alzheimer's disease (AD) is one of the most common neurodegenerative diseases with a commonly seen p...
BACKGROUND: The International Challenge for Automated Prediction of MCI from MRI data offered indepe...
The depression, anxiety and physiosomatic symptoms (DAPS) of schizophrenia are associated with negat...
BACKGROUND: The novel molecule endocan, which is released by endothelium and is regulated by proangi...